General Hospital Psychiatry
Volume 23, Issue 4 , Pages 215-222 , July 2001

A prospective study of posttraumatic stress symptoms and nonadherence in survivors of a myocardial infarction (MI)

  • Eyal Shemesh, M.D.

      Affiliations

    • Department of Psychiatry and Pediatrics, Mount Sinai Medical Center, New York, NY, USA
    • Eyal Shemesh was awarded the American Psychiatric Association/Lilly 1999–2000 resident research award for this manuscript.
    • Corresponding Author InformationCorresponding author. Tel.: +1-212-659-9143; fax: +1-212-659-9291
    • ,
  • Abraham Rudnick, M.D., Ph.D. (MPsych)

      Affiliations

    • Whitby Mental Health Center and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    • Tel Aviv Brull Community Mental Health Center, Ramat-Chen, Israel
    • ,
  • Edo Kaluski, M.D.

      Affiliations

    • Cardiology Institute, Assaf-Harofeh Medical Center, Zerifin, Israel
    • Clinical Pharmacological Research Unit, Zerifin, Israel
    • ,
  • Olga Milovanov, M.D.

      Affiliations

    • Clinical Pharmacological Research Unit, Zerifin, Israel
    • ,
  • Ahmed Salah, R.N.

      Affiliations

    • Clinical Pharmacological Research Unit, Zerifin, Israel
    • ,
  • Daniela Alon, R.N.

      Affiliations

    • Clinical Pharmacological Research Unit, Zerifin, Israel
    • ,
  • Irit Dinur, R.N.

      Affiliations

    • Cardiology Institute, Assaf-Harofeh Medical Center, Zerifin, Israel
    • ,
  • Alex Blatt, M.D.

      Affiliations

    • Cardiology Institute, Assaf-Harofeh Medical Center, Zerifin, Israel
    • Clinical Pharmacological Research Unit, Zerifin, Israel
    • ,
  • Mikael Metzkor

      Affiliations

    • Clinical Pharmacological Research Unit, Zerifin, Israel
    • ,
  • Ahuva Golik, M.D.

      Affiliations

    • Clinical Pharmacological Research Unit, Zerifin, Israel
    • Department of Medicine “A” Assaf-Harofeh Medical Center, Zerifin, Israel
    • ,
  • Zvi Verd, M.D.

      Affiliations

    • Cardiology Institute, Assaf-Harofeh Medical Center, Zerifin, Israel
    • ,
  • Gad Cotter, M.D.

      Affiliations

    • Cardiology Institute, Assaf-Harofeh Medical Center, Zerifin, Israel
    • Clinical Pharmacological Research Unit, Zerifin, Israel

References 

  1. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. Arch Intern Med. 1997;157:1921–1929
  2. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of Propranolol in patients with acute MI, I (mortality results). JAMA. 1982;247:1707–1714
  3. Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after MI in women. JAMA. 1994;270:742–744
  4. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med. 1980;303:1038–1041
  5. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190–1195
  6. Stegman MR, Miller PJ, Hageman RK, et al.  MI survival (how important. are patient’s attitudes, and adherence behaviors?). Am J Prev Med. 1987;3:147–151
  7. Goldberger JJ, Peled HB, Stroh JA, et al.  Prognostic factors in acute pulmonary edema. Arch Intern Med. 1988;146:489–493
  8. Reis GJ, Sipperly ME, McCabe GH, et al.  Randomized trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet. 1989;2:177–181
  9. Romm FJ, Hulka BS, Mayo F. Correlates of outcomes in patients with congestive heart failure. Med Care. 1976;14:765–776
  10. Coons SJ, Sheahan SL, Martin SS, et al.  Predictors of medication noncompliance in a sample of older adults. Clinical Therapeutics. 1994;16:110–117
  11. Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer (perceived. risk, psychological well-being, and surveillance behavior). J Natl Cancer Inst Monogr. 1994;16:171–176
  12. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP. Medical compliance, and its predictors in the first year after heart transplantation. J Heart Lung Transplant. 1996;15:631–645
  13. Sampson JJ, Arbona CL. Causes and effects of noncompliance in cardiac patients. Clin Cardiol. 1980;3:207–210
  14. Shapiro PA, Williams DA, Foray AT, Gelman IS, Wukich N, Sciacca R. Psychosocial evaluation, and prediction of compliance problems, and morbidity after heart transplantation. Transplantation. 1995;60:1462–1466
  15. Goldston DB, Kelley AE, Reboussin DM, et al.  Suicidal ideation and behavior and noncompliance with the medical regimen among diabetic adolescents. J Am Acad Child Adolesc Psychiatry. 1997;36:1528–1536
  16. De Geest S, Borgermans L, Gemoets H, et al.  Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995;59:340–347
  17. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant. 1994;8:550–557
  18. Shemesh E, Shneider BL, Stuber ML, et al. A pilot study of symptoms of post traumatic stress disorder and nonadherence in pediatric liver transplant recipients. Pediatrics 2000;105:e29 1–7.
  19. American Psychiatric Association. In: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edn. (DSM-IV). Washington, DC: American Psychiatric Association; 1994;p. 428–429
  20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edn. (DSM-IV). Washington, D.C.: American Psychiatric Association, 1994. p. 424.
  21. Kutz I, Shabtai H, Solomon Z, Neumann M, David D. Post traumatic stress disorder in MI patients (prevalence study). Isr J Psychiatry Relat Sci. 1994;31:48–56
  22. Doerfler LA, Pbert L, DeCoimo D. Symptoms of posttraumatic stress disorder following MI and coronary artery bypass surgery. Gen Hosp Psychiatry. 1994;16:193–199
  23. Criteria Committee, New York Heart Association Inc. Diseases of the heart and blood vessels, nomenclature and criteria for diagnosis. Sixth Edn. Boston: Little, Brown, and Co., 1964. p. 114–60.
  24. Campeau L. Grading of angina pectoris. Circulation. 1976;54:522–530
  25. Horowitz M, Wilner N, Alvarez W. Impact of event scale (a measure of subjective stress). Psychosomatic Med. 1979;41:209–218
  26. Laor N, Wolmer L, Mayes LC, et al.  Israeli preschoolers under the scuds (a developmental perspective on the “protective matrix” as a risk-modifying-function). Arch Gen Psychiatry. 1996;53:416–423
  27. Laor N, Wolmer L, Mayes LC, Gershon AG, Weizman R, and Cohen DJ. Israeli preschool children under scuds: A 30-month follow-up.
  28. Derogatis LR, Rickels K, Rock AF. The SCL-90, and the MMPI (a step in the validation of a new self-report scale). British J Psychiatry. 1976;128:280–289
  29. Derogatis LR. SCL-90-R (Administration, scoring, procedures manual II). Second Edn.. Towson, MD: Clinical Psychometrics Research; 1983;
  30. Johnson SB. Measuring adherence. Diabetes Care. 1992;15:1658–1667
  31. Ramsay JA. Participants in noncompliance research (compliant or noncompliant?). Med Care. 1982;20:615–622
  32. Countermanche DL, Robinow O. Recognition and treatment of the posttraumatic stress disorder in the burn victim. J Burn Care Rehabil. 1989;10:247–250
  33. Brady KT. Posttraumatic stress disorder and comorbidity: recognizing the many faces of PTSD. J Clin Psychiatry 1997;58(suppl) 9:12–5.
  34. Beckham JC, Moore SD, Feldman ME, Hertzberg MA, Kirby AC, Fairbank JA. Health status, somatization, and severity of posttraumatic stress disorder in Vietnam combat veterans with posttraumatic stress disorder. Am J Psychiatry. 1998;155:1565–1569
  35. Andreski P, Chilcoat H, Breslau N. Post-traumatic stress disorder and somatization symptoms a prospective study. Psychiatry Res. 1998;79:131–138
  36. Van Der Kolk BA, Pelcovitz D, Roth S, Mandel FS, McFarlane A, Herman JL. Dissociation, somatization, and affect dysregulation (the complexity of adaptation of trauma). Am J Psychiatry. 1996;153(7 suppl):83–93
  37. Amanda-Dew M, Kormos RL, Roth LH, Murali A, Griffith BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999;18:549–562
  38. Shankin Kunkel EJ, Woods CM, Rodgers C, Myers RE. Consultations for “maladaptive denial of illness” in patients with cancer (psychiatric disorders that result in noncompliance). Psycho-Oncology. 1997;6:139–149
  39. Fricchione GL, Howanitz E, Jandorf L, Kroessler D, Zervas I, Woznicki RM. Psychological adjustment to end-stage renal disease, and the implications of denial. Psychosomatics. 1992;33:85–91
  40. Matsui DR. Drug compliance in pediatrics—clinical and research issues. Pediatr Clin North Am. 1997;44:1–14
  41. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation. 1990;49:374–377
  42. Didlake RH, Dreyfus K, Kerman RH, Van Buren C, Kahan B. Patient noncompliance (a major cause of late graft failure in cyclosporine —treated renal transplants). Transplant Proc. 1988;20:63–69
  43. Leventhal H, Cameron L. Behavioral theories and the problem of noncompliance. Pat Educ Couns. 1987;10:117–138
  44. Litt I, Cuskey WR. Compliance with medical regimens during adolescence. Pediatr Clin North Am. 1982;27:3–15
  45. Smyth JM, Stone AA, Hurewitz A, Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis. JAMA. 1999;281:1304–1309
  46. Holland JC. Use of alternative medicine—a marker for distress?. N Engl J Med. 1999;340:1758–1759

PII: S0163-8343(01)00150-5

General Hospital Psychiatry
Volume 23, Issue 4 , Pages 215-222 , July 2001

Article Tools

* Image Usage & Resolution